Delivery Order SPE2DB20D3101-SPE2DB25FRLJ6
Award Date
5/28/25
Potential Completion Date
5/29/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,350.18, is for the delivery of telmisartan-amlodipine 40-10 30S, a cardiovascular medication. The contract has an ultimate completion date of January 27, 2025 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,676.43 Firm Fixed Price Delivery Order contract is for the provision of Telmisartan-Amlodipine 80-10 30S, a cardiovascular medication, with a completion date of June 18, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,058.68, is for the delivery of Telmisartan-Amlodipine 80-5 mg medication in 30-count packages. The contract has a completion date of December 15, 2023 and is a Firm Fixed Price Delivery Order. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,903.92 firm fixed-price delivery order covers the supply of Telmisartan-Amlodipine 40-10 30S, a cardiovascular medication, with a performance period extending through January 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan-Amlodipine 40-5 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $2,005.00. It has an ultimate completion date of July 31, 2024. This award is not associated with a set-aside program. AmerisourceBergen, the prime contractor, will be providing these essential...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,631.94, is a delivery order for the supply of Telmisartan-Amlodipine 40-5 mg tablets. The contract has an ultimate completion date of March 7, 2025 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,155.42, is for the delivery of TELMISARTAN-AMLODIPINE 80-5 MG 30S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan-Amlodipine 40-5 mg tablets. The $2,774.37 Firm Fixed Price delivery order contract has an ultimate completion date of September 11, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,992.64 firm fixed-price delivery order is for the supply of Telmisartan-Amlodipine 80-10 30S, a cardiovascular medication, with a period of performance through February 7, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award, valued at $2,648.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Telmisartan-Amlodipine 40-5 mg tablets, which are used to treat cardiovascular conditions. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price agreement. AmerisourceBergen holds a significant Indefinite...